I.C.I. 50172 demonstrates anti-arrhythmic properties in vivo that are disproportionately higher than its in vitro local anaesthetic and beta-blocking activities compared to propranolol.
Answers are grounded in this paper and cite their sources.
May indicate antiarrhythmic effects independent of local anaesthesia in animals; leaves open translation to human arrhythmias.
I.C.I. 50172 had marked quinidine-like effects on intracellular cardiac action potentials at concentrations above 20 mg/l. (6.61 x 10(-5)M). The rate of rise and overshoot of the action potential, conduction velocity and contractions were decreased. (-)-Propranolol had similar effects at less than 1/30 this concentration.2. I.C.I. 50172 had 1/100 the activity of (-)-propranolol as a local anaesthetic. Since this is also the ratio of their in vitro beta-receptor blocking activities, I.C.I. 50172 provides no net increase in specificity of beta-receptor blockade.3. In contrast, the in vivo activity of I.C.I. 50172 in protecting anaesthetized guinea-pigs against ouabain-induced ventricular fibrillation was 40% that of (-)-propranolol.4. Structure-activity relations of beta-receptor blocking drugs are discussed.
No takes yet. Share an insight, caveat, or question.
Papp et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: